Tandem Diabetes Care Announces Executive and Board Changes
Ticker: TNDM · Form: 8-K · Filed: Jun 21, 2024 · CIK: 1438133
| Field | Detail |
|---|---|
| Company | Tandem Diabetes Care Inc (TNDM) |
| Form Type | 8-K |
| Filed Date | Jun 21, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $450,203.73 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-changes, personnel
Related Tickers: TNDM
TL;DR
Tandem Diabetes Care shakes up exec team and board on June 19th.
AI Summary
On June 19, 2024, Tandem Diabetes Care, Inc. announced changes in its executive team and board of directors. The company appointed new officers and elected new directors, alongside adjustments to its compensatory arrangements for certain officers.
Why It Matters
Changes in key leadership and board composition can signal shifts in company strategy, operational focus, or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and leadership stability.
Key Numbers
- 001-36189 — SEC File Number (Identifies the company's filings with the SEC.)
- 20-4327508 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Tandem Diabetes Care, Inc. (company) — Registrant
- June 19, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Diego (location) — Principal executive offices city
- California (location) — Principal executive offices state
FAQ
What specific roles were affected by the executive and board changes?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers,' but does not specify the exact roles in this summary.
Were there any specific reasons cited for the departures or appointments?
The provided text does not detail the specific reasons for the departures or appointments of officers and directors.
What is the effective date of these changes?
The earliest event reported is dated June 19, 2024.
Does the filing mention any changes to executive compensation as part of these announcements?
Yes, the filing explicitly mentions 'Compensatory Arrangements of Certain Officers' as an item of information.
Where is Tandem Diabetes Care, Inc. headquartered?
The company's principal executive offices are located at 12400 High Bluff Drive, San Diego, California.
Filing Stats: 1,010 words · 4 min read · ~3 pages · Grade level 12.3 · Accepted 2024-06-21 16:19:53
Key Financial Figures
- $0.001 — ich Registered Common Stock, par value $0.001 per share TNDM NASDAQ Global Market I
- $450,203.73 — other things: (i) annual base salary of $450,203.73; (ii) target annual bonus under the Cas
Filing Documents
- tndm-20240619.htm (8-K) — 26KB
- 0001438133-24-000166.txt ( ) — 148KB
- tndm-20240619.xsd (EX-101.SCH) — 2KB
- tndm-20240619_lab.xml (EX-101.LAB) — 21KB
- tndm-20240619_pre.xml (EX-101.PRE) — 12KB
- tndm-20240619_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Tandem Diabetes Care, Inc. By: /s/ SHANNON M. HANSEN Shannon M. Hansen Executive Vice President, Chief Legal, Privacy & Compliance Officer and Secretary Date: June 21, 2024 3